Stability and solubility of celecoxib-PVP amorphous dispersions: A molecular perspective

Pharmaceutical Research

Volumn 21, Issue 10, 2004, Pages 1762-1769

  Gupta, Piyush ^a   Kakumanu, Vasu Kumar ^a   Bansal, Arvind K ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

celecoxib; characterization; enthalpy relaxation; molecular dispersion; release mechanisms

Indexed keywords

CELECOXIB; POVIDONE;

ARTICLE; CONTROLLED DRUG RELEASE; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; DRUG SOLUBILITY; DRUG STABILITY; ENTHALPY; GLASS TRANSITION TEMPERATURE; MICROSCOPY; MOLECULAR MECHANICS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; X RAY POWDER DIFFRACTION;

ALGORITHMS; CALORIMETRY, DIFFERENTIAL SCANNING; CRYSTALLOGRAPHY, X-RAY; DRUG STABILITY; MICROSCOPY, POLARIZATION; MODELS, CHEMICAL; PHARMACEUTIC AIDS; POVIDONE; PYRAZOLES; SOLUBILITY; SULFONAMIDES; SUSPENSIONS; THERMODYNAMICS;

EID: 6344247455     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:PHAM.0000045226.42859.b8     Document Type: Article

References (26)

1. A. A. Elamin, C. Ahlneck, G. Alderborn, and C. Nystrom. Increased metastable solubility of milled griseofulvin, depending on the formation of a disordered surface structure. Int. J. Pharm. 111:159-170 (1994).
2. A. T. M. Serajuddin. Solid dispersions of poorly water-soluble drugs: early promises, subsequent problems and recent breakthroughs. J. Pharm. Sci. 88:1058-1066 (1999).
3. W. L. Chiou and S. T. Reigelman. Oral absorption of griseofulvin in dogs. Increased absorption via solid dispersion in polyethylene glycol 6000. J. Pharm. Sci. 59:937-942 (1970).
4. W. L. Chiou and S. Riegelman. Pharmaceutical applications of solid dispersions. J. Pharm. Sci. 60:1281-1302 (1971).
5. B. C. Hancock and M. Parks. What is the true solubility advantage for amorphous pharmaceuticals? Pharm. Res. 17:397-404 (2000).
6. P. H. Poole, T. Grande, C. A. Angell, and P. F. McMillan. Polymorphic phase transitions in liquids and glasses. Science 275:322-323 (1997).
7. B. C. Hancock, S. L. Shamblin, and G. Zografi. The molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures. Pharm. Res. 12:799-806 (1995).
8. M. D. Ediger, C. A. Angell, and S. R. Nagel. Supercooled liquids and glasses. J. Phys. Chem. 100:13200-13212 (1996).
9. B. C. Hancock. Disordered drug delivery: destiny, dynamics and the Deborah number. J. Pharm. Pharmacol. 54:737-746 (2002).
10. B. C. Hancock, E. Y. Shalaev, and S. L. Shamblin. Polyamorphism: a pharmaceutical perspective. J. Pharm. Phamacol 54: 1151-1152 (2002).
11. D. Q. M. Craig. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int. J. Pharm. 231:131-144 (2002).
12. O. I. Corrigan. Mechanisms of dissolution of fast release solid dispersions. Drug Dev. Ind. Pharm. 11:697-724 (1985).
13. B. C. Hancock and G. Zografi. Characteristics and significance of the amorphous state in pharmaceutical systems. J. Pharm. Sci. 86:1-12 (1997).
14. A. R. Paradkar, B. Chauhan, S. Yamamuri, and A. P. Pawar. Preparation and characterization of glassy celecoxib. Drug Dev. Ind. Pharm. 29:739-744 (2003).
15. G. Chawla, P. Gupta, R. Thilagavathi, A. K. Chakraborti, and A. K. Bansal. Characterization of solid-state forms of celecoxib. Eur. J. Pharm. Sci. 20:305-317 (2003).
16. V. K. Kakumanu and A. K. Bansal. Enthalpy relaxation studies of celecoxib amorphous mixtures. Pharm. Res. 19:1873-1878 (2002).
17. G. V. Mooter, M. Wuyts, N. Blaton, R. Busson, P. Grobet, P. Augustijns, and R. Kinget. Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25. Eur. J. Pharm. Sci. 12:261-269 (2001).
18. S. L. Shamblin, L. S. Taylor, and G. Zografi. Mixing behavior of colyophilized binary systems. J. Pharm. Sci. 87:694-701 (1998).
19. B. C. Hancock and G. Zografi. The relationship between the glass transition temperature and the water content of amorphous pharmaceutical solids. Pharm. Res. 11:471-477 (1994).
20. I. Kushida and K. Ashizawa. Solid state characterization of E2101, a novel antispastic drug. J. Pharm. Sci. 91:2193-2202 (2002).
21. S. Verheyen, N. Blaton, R. Kinget, and G. V. Mooter. Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 solid dispersions. Int. J. Pharm. 249:45-58 (2002).
22. C. A. Lipinski, F. Lombardo, B. W. Dominy, and P. J. Feeney. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Del. Rev. 46:3-26 (2001).
23. N. Najib and M. Suleiman. The kinetics of drug release from ethyl cellulose solid dispersions. Drug Dev. Ind. Pharm. 11:2169-2181 (1985).
24. S. J. Desai, P. Singh, A. P. Simonelli, and W. I. Higuchi. Investigation of factors influencing release of solid drug dispersed in wax matrices III. Quantitative studies involving polyethylene plastic matrix. J. Pharm. Sci. 55:1230-1234 (1966).
25. H. M. Abdou. Theory of dissolution. In A. Gennaro, B. Migdalof, G. L. Hassert, and T. Medwick (eds.), Dissolution, Bioavailability and Bioequivalence. MACK Publishing, Easton, PA, 1989 pp. 11-36.
26. R. W. Baker and H. K. Lonsdale. Controlled Release of Biological Active Agents. Wiley, New York, 1987.